
Vitls
The world's most innovative vital signs platform for remote and continuous monitoring..
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | - | ||
Total Funding | 000k |
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | (29 %) | - |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Vitls Inc. specializes in continuous vital sign monitoring through its innovative Tego device and Vitls App, aimed at improving patient outcomes and satisfaction. Operating in the healthcare technology market, Vitls serves hospitals, pediatric care units, and other medical facilities. The business model revolves around selling its wearable medical devices and subscription-based cloud services that provide actionable patient data. Revenue is generated through device sales and recurring subscription fees for data analysis and monitoring services. Vitls' technology enables nurses and physicians to receive continuous, accurate, and reliable patient data, allowing for quick and informed medical decisions. The company was founded by Werner Vorster, inspired by personal experiences with his son's health challenges. Vitls is committed to making continuous vital sign monitoring the standard of care in hospitals, ensuring immediate notification to care providers if any physiological parameters change.
Keywords: continuous monitoring, vital signs, cloud-based analysis, healthcare technology, pediatric care, wearable devices, patient outcomes, data analytics, medical decision-making, subscription services.